Adaptive ChemoTherapy for Ovarian Cancer in Patients With Replased Platinum-sensitive High Grade Serous or High Grade Endometrioid Ovarian Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Ovarian Cancer · Relapsed Ovarian Cancer · Fallopian Tube Cancer · Peritoneal Cancer · Endometrioid Carcinoma · High Grade Serous Carcinoma · Ovary Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University College London Hospitals, London, United Kingdom
Contact: Study coordinator (Michelle Lockley) · michellelockley@nhs.net
Contact: Principal Investigator (Michelle Lockley)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

Cancer · Breast Cancer · Non-Small Cell Lung Cancer (NSCLC)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Beijing, China

Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients

Cancer · Breast Cancer · Gastric Cancer

Abroad (travel likely)Recruiting

Bron, France · Lyon, France

Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer

Ovarian Cancer · Fallopian Tube Cancer · Primary Peritoneal Cancer

Abroad (travel likely)RecruitingPHASE2

Birmingham, United States · La Jolla, United States

A Beta-only IL-2 ImmunoTherapY Study

Advanced Solid Tumor · Unresectable Solid Tumor · Clear Cell Renal Cell Carcinoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

San Diego, United States · San Francisco, United States